Music icon Barry Manilow today revealed his long struggle to manage a serious heart disease called atrial fibrillation (AFib). He has joined with Sanofi US to kick-off Get Back in Rhythm™, a national education campaign to raise awareness about AFib, and to encourage people to learn more about all the risks of AFib and the importance of keeping the heart in rhythm.
Today, approximately 2.5 million Americans have AFib and that number is expected to grow to 12 million by 2050. A serious heart disease that causes the heart to race and beat out of rhythm, AFib can lead to permanent heart damage, heart attack, heart failure, stroke and death.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51813-get-back-in-rhythm-barry-manilow-afib-awareness
Wiping up finger paint and tackling juice spills is a routine every parent has down pat. Yet they may find themselves playing hide-and-seek with the invisible things little hands leave behind—like bacteria and viruses. Germs stick to all types of surfaces, and kids spread them to more places than you can imagine.
To track down where germs linger, The Clorox Company and global public health organization NSF International conducted a study in homes of families with young children. Researchers analyzed 100 samples from five commonly-touched surfaces, and found bacteria or viruses on all five of the surfaces tested, from the kitchen to the common area to the bathroom, with the bathroom sink being one of the surfaces with the most germs. In fact, the study results found that four times as many households had bathroom sinks that were germier than kitchen countertops.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7359251-clorox-and-nsf-study-shows-which-surfaces-have-most-germs-in-homes-with-kids
One of every ten euros of the gross domestic product is gained through health care. And, despite Germanys image of being a nation of motorists actually the most patents are filed in the medical field. It is therefore no wonder that German Chancellor Angela Merkel paid a visit to the world's largest medical trade fair MEDICA in Duesseldorf. Also present was the Minister of health Dr. Philipp Rösler, who prepared for the upcoming tasks at the Hospital day which runs parallel to the fair.
George Freeman MP, the Minister for Life Sciences, will give the keynote address at the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
Organised and funded by Astellas, a progressive pharmaceutical company that explores the frontiers of scientific discovery to translate new knowledge into innovative, reliable medicines, the Astellas Innovation Debates are a series of annual events that bring together some of the world’s most progressive thinkers to discuss the role of innovation in solving some of the greatest challenges of our time.
George Freeman’s keynote address will outline the Government’s aim to develop, assess and adopt new drugs, devices and diagnostics as we move towards 21st century, personalised healthcare.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7423951-george-freeman-astellas-debate/
On July 21, 2014, Genworth (NYSE:GNW) is introducing Privileged Choice® Flex 3 featuring FlexFit℠ packages. FlexFit packages are designed to help address the primary barriers to purchasing long term care insurance – price and complexity. FlexFit gives millions more Americans the flexibility to choose the right fit for their long term care needs, combined with the simplicity of prepackaged benefits. Privileged Choice Flex 3 is issued by Genworth Life Insurance Company.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7206252-genworth-offers-affordable-flexfit-long-term-life-insurance/
According to Genworth’s (NYSE: GNW) 2012 Cost of Care Survey, the cost to receive care in the home remained unchanged from 2011 to 2012 and home care costs have also risen less dramatically over the past five years than for other types of long term care services.
“Overwhelmingly, Americans prefer to receive long term care in the home and the relatively muted increase in home care costs over the past few years can be viewed as a positive for consumers,” said Steve Zabel, senior vice president of Long Term Care at Genworth. “Consumer demand for home care services has led to a proliferation of home care services providers and more choice for consumers. This competition has kept home care costs relatively stable, especially when compared to the cost of care in a nursing home or assisted living facility.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/54344-genworth-financial-2012-cost-of-care-survey-long-term-care
General Mills Cereals has committed to removing artificial flavors and colors from artificial sources from the rest of its cereals in response to consumers’ changing preferences. Today, more than 60 percent of General Mills Cereals like Cinnamon Toast Crunch and Original Cheerios are already without artificial flavors and colors from artificial sources and have been that way for a long time.
According to a survey conducted by Nielsen on behalf of General Mills, 49 percent of households are making an effort to avoid artificial flavors and colors from artificial sources.(1) To respond to this growing need, General Mills Cereals will be using more recognizable, familiar ingredients to create its colors and flavors.
To view the Multimedia News Release, go http://www.multivu.com/players/English/7557051-general-mills-cereals-artificial-free/
Adolescents and young adults with a severe inherited immunodeficiency disorder improved following treatment with novel gene therapy developed at St. Jude Children’s Research Hospital and at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The results of this study appear today in the journal Science Translational Medicine.
The study involved five males with X-linked severe combined immunodeficiency disease (SCID-X1), also known as “Bubble Boy” disease, who were all treated at NIAID. This inherited disorder involves a mutation in the IL2RG gene that affects males and occurs in 1 of every 50,000 to 100,000 live births, leaving them with little to no immune protection.
To view the multimedia release go to:
http://www.multivu.com/players/English/7808651-st-jude-gene-therapy-results/
GB Sciences, Inc. (OTCQB: GBLX) announces the success of its first annual, “Innovation in Medical Cannabis Therapies” (IMCT) Symposium, held on Friday, November 9th at the “Keep Memory Alive” Event Center at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, Nevada. Throughout the day’s program, there was an emerging sense of heightened responsibility on the part of the cannabis industry to better address medical cannabis patients' needs through research and development of medical cannabis products that are better standardized, more easily-dosed, and made more widely-available to cannabis patients at a fair price.
To view the multimedia release go to:
https://www.multivu.com/players/English/8308958-gb-sciences-2018-medical-cannabis-therapies-symposium/
Having lost his mother to the disease, singer, songwriter Gavin DeGraw knows firsthand how devastating pancreatic cancer is for patients and their families. Gavin is turning his grief into action by helping the Lustgarten Foundation raise awareness by encouraging people to get involved with the Foundation.
“My mother didn’t make it and unfortunately right now that’s a common story. But it doesn’t have to be the story permanently,” DeGraw said. “By funding research, the Lustgarten Foundation is going to change the course of this disease. I encourage everyone to get involved in some way – join a walk or make a donation.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213753-lustgarten-foundation-pancreatic-cancer-awareness/
There is a bankruptcy involving claims about exposure to asbestos-containing gaskets, packing, and equipment. Garlock Sealing Technologies LLC, The Anchor Packing Company, and Garrison Litigation Management Group, Ltd., along with representatives of asbestos claimants, have filed a new plan of reorganization (the “Plan”). Coltec Industries Inc is also part of the Plan. If claimants approve the Plan, Coltec will merge with a company known as OldCo, LLC, and that company will file a bankruptcy case. Together, these companies are referred to as the “Debtors.”
The gaskets and packing were used in places where steam, hot liquid, or acids moved through pipes, including industrial and maritime settings. The equipment included compressors, engines, pumps, transformers, and other equipment that may have had asbestos-containing components, such as gaskets or packing. The Coltec-related divisions or businesses that may have sold asbestos-containing products or equipment were Fairbanks Morse, Quincy Compressor, Central Moloney, Delavan, France Compressor, and Farnam.
To view the multimedia release go to:
http://www.multivu.com/players/English/7904751-garlock-coltec-asbestos-bankruptcy/
